Clinical Trials Logo

Hypotension clinical trials

View clinical trials related to Hypotension.

Filter by:

NCT ID: NCT00452972 Completed - Pain Clinical Trials

Exteriorized Versus In Situ Uterine Repair at Cesarean Delivery

Start date: April 2004
Phase: N/A
Study type: Interventional

This study was undertaken to compare the two techniques (exteriorized vs in situ) of uterine repair with respect to patient comfort, hemodynamic changes, surgical time and blood loss, in patients undergoing elective CD under a strictly standardized spinal anesthetic. We hypothesized that in situ uterine repair would be more comfortable for the patients.

NCT ID: NCT00452712 Recruiting - Fever Clinical Trials

Orthostatic Hypotension in Children With Acute Febrile Illness

Start date: November 2006
Phase: Phase 2
Study type: Observational

Objective:to determent if children suffering from acute febrile illness has higher rate of orthostatic hypotension compared with children with no febrile illness. Design: a prospective cohort study. Subjects: children aged 4-18 year with fever (temperature > 38.) for up to 48 hours, presenting to the pediatric emergency department. Interventions: All subjects will have their blood pressure measured in supine position (after 5 minute of rest) and after 3 minute of standing.

NCT ID: NCT00448071 Recruiting - Clinical trials for End Stage Renal Disease

Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients

Start date: May 2006
Phase: Phase 2
Study type: Interventional

MTR107 effect on blood pressure throught the dialysis procedure and its ability to prevent Intra dialytic Hypotension

NCT ID: NCT00431288 Completed - Hypertension Clinical Trials

A Nutrition Intervention to Lower Blood Pressure in Adolescents

Start date: August 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of a 12-week, clinic-based, behavioral nutrition intervention emphasizing fruits, vegetables, and low fat dairy compared to routine nutrition care on changing diet quality and blood pressure post-treatment and at short-term follow-up in adolescents with hypertension.

NCT ID: NCT00426842 Completed - Spinal Cord Injury Clinical Trials

A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride

Start date: January 2007
Phase: Phase 2
Study type: Interventional

With upright postures, there is an immediate redistribution of blood to the dependent circulation; venous return and central venous filling pressure are reduced, resulting in diminution of cardiac output and blood pressure. These hemodynamic alterations stimulate the baroreceptor reflex, which is mediated via the central nervous system to increase peripheral sympathetic vasomotor tone, restoring blood pressure and cardiac output within seconds-to-minutes of the assumption of the upright position. Following SCI, individuals often experience the inability to adjust to postural changes due to disruption of central command of the baroreceptor reflex and reduction in efferent sympathetic neural pathways; consequently, orthostatic hypotension (OH) and symptoms of cerebral hypo-perfusion may ensue. OH is a well-documented phenomenon, which is characterized by a fall in systolic blood pressure of >20 mmHg or diastolic BP of > 10 mmHg within 3 minutes of assumption of an upright posture. As a consequence of OH, many individuals experience symptoms of cerebral hypo-perfusion which include lightheadedness, dizziness, blurry vision, fatigue, nausea, ringing in the ears, cognitive impairment and heart palpitations. Although several investigators have reported increased prevalence of OH during the acute phase of spinal cord injury (SCI), individuals with chronic injury also experience significant falls in blood pressure with seated upright postures. This investigation will examine the effects of an alpha-agonist, midodrine hydrochloride, during head-up tilt on systemic blood pressure, cerebral blood flow and cerebral oxygenation compared to placebo administration in persons with chronic SCI who demonstrate significant orthostatic hypotension during a 24-hour observation study. This is the first study to determine the dose response and efficacy of midodrine to improve orthostatic blood pressure and cerebral blood flow and oxygenation in the SCI population.

NCT ID: NCT00425581 Withdrawn - Hypotension Clinical Trials

N-Terminal Pro-B-Type Natriuretic Peptide and Troponin Levels as Markers of Hemodynamic Stability in Very Low Birth Weight Infants During the First Days of Life

Start date: February 2007
Phase: N/A
Study type: Observational

The primary objective is to test the hypothesis that there is an association between the hemodynamic status and the serum levels of NT-proBNP and cTnT in prematurely born infants. We would also evaluate the hypothesis that there is an association between the level of these proteins in the serum and the short and long term morbidity.

NCT ID: NCT00421200 Completed - Hypotension Clinical Trials

Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty

Start date: February 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether Hemospan is superior to Voluven for preventing hypotensive episodes during the perioperative period (from induction of spinal anesthesia until 6 hours after skin closure), and for reducing the incidence of operative and postoperative complications including organ dysfunction and failure until follow-up at one month following surgery. An independent Data Safety Monitoring Board (DSMB) will periodically evaluate the safety data collected during this trial.

NCT ID: NCT00420277 Completed - Hypotension Clinical Trials

Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty

Start date: February 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether Hemospan is superior to Voluven for treatment of hypotensive episodes during the perioperative period (from induction of spinal anesthesia until 6 hours after skin closure), and for reducing the incidence of operative and postoperative complications including organ dysfunction and failure until follow-up at one month following surgery. An independent Data Safety Monitoring Board (DSMB) will periodically evaluate the safety data collected during this trial

NCT ID: NCT00379691 Completed - Hypotension Clinical Trials

Ideal Dose of Phenylephrine to Treat Low Blood Pressure During Cesarean Section

Start date: August 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the minimum effective bolus dose of phenylephrine to prevent post-spinal hypotension in Cesarean section in 95 % of our patients. An adequate response will be defined as the absence of hypotension or nausea/vomiting during the period from induction of spinal anesthesia to uterine incision prior to fetal delivery.

NCT ID: NCT00358748 Completed - Clinical trials for Neonatal Hypotension

Early Use of Hydrocortisone in Hypotensive Very Low Birth Weight Infants

Start date: July 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the early use of hydrocortisone in hypotensive very low birth weight infants. Based on the observations that: - hypotension is a common problem in very low birthweight infants and is associated with brain injury and poor neurological outcomes; - some infants are refractory to standard treatment (volume expansion and vasopressors), which is not exempt of adverse effects; - relative adrenal insufficiency has been described in this population; we hypothesize that hydrocortisone is effective in the treatment of hypotension in this population and reduce the need for vasopressors.